Adult Patients’ Perspectives on the Benefits and Harms of Overused Screening Tests: a Qualitative Study

Journal of General Internal Medicine

Volumn 30, Issue 11, 2015, Pages 1618-1626

  Sutkowi Hemstreet, Anne ^a   Vu, Maihan ^a   Harris, Russell ^a,b,c   Brewer, Noel T ^a,c   Dolor, Rowena J ^d   Sheridan, Stacey L ^a,b,c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c University of North Carolina at Chapel Hill   (United States)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Medical decision making; Patient education; Preventive care; Qualitative research; Screening

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SCREENING; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; FAMILY; FEMALE; FOLLOW UP; GROUPS BY AGE; HEALTH INSURANCE; HUMAN; HYBRID; LOW RISK PATIENT; MALE; MIDDLE AGED; MULTICENTER STUDY; OSTEOPOROSIS; OVERUSED SCREENING TEST; PATIENT ATTITUDE; PROSTATE CANCER; QUALITATIVE RESEARCH; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; RISK FACTOR; SCREENING TEST; SEMI STRUCTURED INTERVIEW; THEMATIC ANALYSIS; VERY ELDERLY; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COLONIC NEOPLASMS; DECISION MAKING; EARLY CANCER DIAGNOSIS; MASS SCREENING; NORTH CAROLINA; PATIENT EDUCATION; PRIMARY HEALTH CARE; PROCEDURES; PROSTATIC NEOPLASMS; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; UNNECESSARY PROCEDURE; UTILIZATION;

AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASES; COLONIC NEOPLASMS; DECISION MAKING; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NORTH CAROLINA; OSTEOPOROSIS; PATIENT EDUCATION AS TOPIC; PRIMARY HEALTH CARE; PROSTATIC NEOPLASMS; QUALITATIVE RESEARCH; UNNECESSARY PROCEDURES;

EID: 84942618138     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-015-3283-9     Document Type: Article

References (59)

1. Berwick DM, Hackbarth AD. Eliminating waste in US health care. JAMA. 2012;307(14):1513–1516.
2. Fuchs VR. Eliminating “waste” in health care. JAMA. 2009;302(22):2481–2482.
3. Korenstein D, Falk R, Howell EA, Bishop T, Keyhani S. Overuse of health care services in the United States: an understudied problem. Arch Intern Med. 2012;172(2):171–178.
4. Kale MS, Bishop TF, Federman AD, Keyhani S. Trends in the overuse of ambulatory health care services in the United States. JAMA Intern Med. 2013;173(2):142–148.
5. Harris RP, Sheridan SL, Lewis CL, Barclay C, Vu MB, Kistler CE, et al. The harms of screening: a proposed taxonomy and application to lung cancer screening. JAMA Intern Med. 2013;174(2):281–5.
6. Kilo CM, Larson EB. Exploring the harmful effects of health care. JAMA. 2009;302(1):89–91.
7. Brody H. Medicine’s ethical responsibility for health care reform—the Top Five list. N Engl J Med. 2010;362(4):283–285.
8. Cassel CK, Guest JA. Choosing wisely: helping physicians and patients make smart decisions about their care. JAMA. 2012;307(17):1801–1802.
9. Good Stewardship Working Group. The “top 5” lists in primary care: meeting the responsibility of professionalism. Arch Intern Med. 2011;171(15):1385–1390.
10. Cook DA, Brydges R, Zendejas B, Hamstra SJ, Hatala R. Mastery learning for health professionals using technology-enhanced simulation: a systematic review and meta-analysis. Acad Med. 2013;88(8):1178–1186.
11. Moyer V, LeFevre M, Siu A. Third Annual Report to Congress onHigh-Priority Evidence Gaps for Clinical Preventive Services. Accessed at: http:uspreventiveservicestaskforce.org/Page/Name/third-annual-report-to-congress-on-high-priority-evidence-gaps-gor-clinical-preventive-services. Accessed April 8, 2015.
12. United States Preventive Services Task Force. USPSTF Recommendations. Available at: http://www.uspreventiveservicestaskforce.org/Page/Name/recommendations. Accessed March 3, 2015.
13. Emanuel EJ, Fuchs VR. The perfect storm of overutilization. JAMA. 2008;299(23):2789–2791.
14. Schwartz LM, Woloshin S, Fowler FJ Jr, Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291(1):71–78.
15. Torke AM, Schwartz PH, Holtz LR, Montz K, Sachs GA. Older adults and forgoing cancer screening: “I think it would be strange”. JAMA Intern Med. 2013;173(7):526–531.
16. United States Preventive Services Task Force. USPSTF Grade Definitions. Available at: http://www.uspreventiveservicestaskforce.org/uspstf/grades.htm. Accessed March 3, 2015.
17. United States Preventive Services Task Force. Screening for Osteoporosis in Postmenapausal Women: Recommendations and Rationale. Ann Intern Med. 2002;137:526–528.
18. United States Preventive Services Task Force. Screening for Osteoporosis: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2011;154:356–364.
19. Moyer VA. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(2):120–134.
20. Moyer VA. Screening for coronary heart disease with electrocardiography: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(7):512–518.
21. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627–637.
22. Chou R, Croswell JM, Dana T, Bougatsos C, Blazina I, Fu R, et al. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155(11):762–771.
23. Chou R, Dana T, Bougatsos C, Fu R, Blazina I, Gleitsmann K, et al. Treatments for Localized Prostate Cancer: Systematic Review to Update the 2002 U.S. Preventive Services Task Force Recommendation. Rockville MD; Agency for Healthcare Research and Quality-October 2011 AHRQ publication number: 12-05161-EF-1.
24. Howlader N, Noone A, Krapcho M, Garshell J, Miller D, Altekruse S, et al. SEER Cancer Statistics Review, 1975–2011. Bethesda, MD: National Cancer Institute October 2013; Available at: http://seer.cancer.gov/csr/1975_2011. Accessed: April 8, 2015.
25. Nelson HD, Haney EM, Dana T, Bougatsos C, Chou R. Screening for osteoporosis: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2010;153(2):99–111.
26. Looker AC, Melton LJ 3rd, Harris TB, Borrud LG, Shepherd JA. Prevalence and trends in low femur bone density among older US adults: NHANES 2005–2006 compared with NHANES III. J Bone Miner Res. 2010;25(1):64–71.
27. Ahmed LA, Schirmer H, Bjornerem A, Emaus N, Jorgensen L, Stormer J, et al. The gender- and age-specific 10-year and lifetime absolute fracture risk in Tromso, Norway. Eur J Epidemiol. 2009;24(8):441–448.
28. Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, et al. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev. 2008, Issue1. Art. No.CD001155.
29. MacLean C, Newberry S, Maglione M, McMahon M, Ranganath V, Suttorp M, et al. Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med. 2008;148(3):197–213.
30. Caplan L, Pittman CB, Zeringue AL, Scherrer JF, Wehmeier KR, Cunningham FE, et al. An observational study of musculoskeletal pain among patients receiving bisphosphonate therapy. Mayo Clin Proc. 2010;85(4):341–348.
31. Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2007;22(10):1479–1491.
32. Black DM, Kelly MP, Genant HK, Palermo L, Eastell R, Bucci-Rechtweg C, et al. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med. 2010;362(19):1761–1771.
33. Schilcher J, Michaelsson K, Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med. 2011;364(18):1728–1737.
34. Abrahamsen B, Pazianas M, Eiken P, Russell RG, Eastell R. Esophageal and gastric cancer incidence and mortality in alendronate users. J Bone Miner Res. 2012;27(3):679–686.
35. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(9):659–669.
36. Warren JL, Klabunde CN, Mariotto AB, Meekins A, Topor M, Brown ML, et al. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med. 2009;150(12):849–857. W152.
37. Levin TR, Zhao W, Conell C, Seeff LC, Manninen DL, Shapiro JA, et al. Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med. 2006;145(12):880–886.
38. Hoffmann U, Massaro JM, Fox CS, Manders E, O’Donnell CJ. Defining normal distributions of coronary artery calcium in women and men (from the Framingham Heart Study). Am J Cardiol. 2008;102(9):1136–1141. 1141 e1131.
39. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358(13):1336–1345.
40. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004;291(2):210–215.
41. Fowler-Brown A, Pignone M, Pletcher M, Tice JA, Sutton SF, Lohr KN. Exercise tolerance testing to screen for coronary heart disease: a systematic review for the technical support for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140(7):W9–W24.
42. Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373(9678):1849–1860.
43. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366(9493):1267–1278.
44. Chou R, Arora B, Dana T, Fu R, Walker M, Humphrey L. Screening asymptomatic adults with resting or exercise electrocardiography: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155(6):375–385.
45. Hippisley-Cox J, Coupland C. Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database. BMJ. 2010;340:c2197.
46. Hernandez-Diaz S, Garcia Rodriguez LA. Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications. BMC Med. 2006;4:22.
47. Miles M, Huberman A. Qualitative Data Analysis. 2nd ed. Thousand Oaks, CA: Sage Publications; 1994.
48. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.
49. Rothberg MB, Sivalingam SK, Ashraf J, Visintainer P, Joelson J, Kleppel R, et al. Patients’ and cardiologists’ perceptions of the benefits of percutaneous coronary intervention for stable coronary disease. Ann Intern Med. 2010;153(5):307–313.
50. Whittle J, Conigliaro J, Good CB, Kelley ME, Skanderson M. Understanding of the benefits of coronary revascularization procedures among patients who are offered such procedures. Am Heart J. 2007;154(4):662–668.
51. Steinberg T, Roseman M, Kasymjanova G, Dobson S, Lajeunesse L, Dajczman E, et al. Prevalence of emotional distress in newly diagnosed lung cancer patients. Support Care Cancer. 2009;17(12):1493–1497.
52. Hoffman RM, Lewis CL, Pignone MP, Couper MP, Barry MJ, Elmore JG, et al. Decision-making processes for breast, colorectal, and prostate cancer screening: the DECISIONS survey. Med Decis Making. 2010;30(5 Suppl):53S–64S.
53. Bowen DJ, Hannon PA, Harris JR, Martin DP. Prostate cancer screening and informed decision-making: provider and patient perspectives. Prostate Cancer Prostatic Dis. 2011;14(2):155–161.
54. Elstad E, Sutkowi-Hemstreet A, Vu M, Sheridan S, Harris R, Reyna V, et al. Clinicians’ perceptions of the benefits and harms of prostate and colorectalcancer screening. Med Decis Making. 2015; e pub ahead of print.
55. Singer E, Couper MP, Fagerlin A, Fowler FJ, Levin CA, Ubel PA, et al. The role of perceived benefits and costs in patients’ medical decisions. Health Expect. 2014;17(1):4–14.
56. Perneger TV, Cullati S, Schiesari L, Charvet-Berard A. Impact of information about risks and benefits of cancer screening on intended participation. Eur J Cancer. 2010;46(12):2267–2274.
57. Perneger TV, Schiesari L, Cullati S, Charvet-Berard A. Does information about risks and benefits improve the decision-making process in cancer screening - randomized study. Cancer Epidemiol. 2011;35(6):574–579.
58. Sheridan SL, Felix K, Pignone MP, Lewis CL. Information needs of men regarding prostate cancer screening and the effect of a brief decision aid. Patient Educ Couns. 2004;54(3):345–351.
59. Volk RJ, Linder SK, Kallen MA, Galliher JM, Spano MS, Mullen PD, et al. Primary care physicians’ use of an informed decision-making process for prostate cancer screening. Ann Fam Med. 2013;11(1):67–74.